Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Diabetes
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Liraglutide for Obesity in Type 2 Diabetes
8
Mins
December 2023
Obesity is a major risk factor for the development of Type 2 diabetes (T2D), with the prevalence of both increasing in a parallel manner…
Read more
9
Mins
2nd March 2017
Cardiovascular Risk Factor Control in Type 2 Diabetes Mellitus and New Trial Evidence
The micro and macrovascular complications of Type 2 diabetes mellitus are influenced by several well described cardiovascular risk factors such as…
13th December 2016
Sedentary Behaviour: A New Target in the Prevention and Management of Diabetes?
Since the early 2000s, an increasing number of studies have focussed on the adverse health effects of sitting. Sitting, together with other activities…
13th December 2016
Management of Cardiovascular Risk Factors in Type 2 Diabetes Mellitus Patients
People with Type 2 diabetes mellitus (T2DM), compared with non-diabetic individuals, have increased cardiovascular risk. Part of this excess risk is…
13
Mins
27th October 2016
Type 2 Diabetes Mellitus: Beyond the Beta Cell
Type 2 diabetes mellitus (T2DM) currently affects >8% of the world population. It is the leading cause of blindness, end-stage kidney disease, and…
9
Mins
27th October 2016
Editor’s Pick: New Drugs for Type 2 Diabetes: New Hopes and New Concerns About the Skeleton
There is growing evidence indicating the effects of medications for Type 2 diabetes mellitus (T2DM) on bone metabolism and fracture risk.
10
Mins
27th October 2016
Treatment of Type 2 Diabetes with Biphasic Insulin Analogues
The majority of patients with Type 2 diabetes require insulin therapy for treating hyperglycaemia. There are several regimens available for insulin…
10
Mins
27th October 2016
Utility of Glycated Haemoglobin in Gestational Diabetes Mellitus: Present and Future
Gestational diabetes mellitus (GDM) is a major public health problem with various complexities involved in its diagnosis. Traditionally an oral glucose…
9
Mins
27th October 2016
Treatment Strategies for Chorioretinal Vascular Diseases: Advantages and Disadvantages of Individualised Therapy
Chorioretinal vascular diseases are among the leading causes of blindness in industrialised countries. The recent development and widespread adoption of…
Loading posts...
« Previous
1
…
10
11
12
13
14
…
16
Next »